Retina/Vitreous News

In this video, Barbara Blodi, MD, discusses advancements in gene therapy for the treatment of age-related macular degeneration.

CARLSBAD, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Lisa M. Nijm, MD, JD, discusses the burden of thyroid eye disease and how it affects quality of life.

The FDA cleared an investigational new drug application for OpCT-001, an investigational cell therapy for the treatment of primary photoreceptor diseases, according to a press release from BlueRock Therapeutics.

Less than 25% of patients with thyroid eye disease who underwent a full course of treatment with Tepezza required re-treatment, according to a study published in Ophthalmology.

Adults receiving teprotumumab for the treatment of thyroid eye disease experience a similar number of hearing-related adverse events as those not treated with teprotumumab, according to new data.

AI showed favorable results in generating accurate responses to multiple questions covering diagnostic criteria, treatment guidelines and management strategies for retinal diseases.

CARLSBAD, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Kelley Sheets of Eyedaptic gives an overview of the Eye6 wearable vision aid for patients with age-related macular degeneration.

Previous unsuccessful topical therapy does not affect outcomes in patients who undergo surgical macular hole repair, according to a study presented at the American Society of Retina Specialists annual meeting.

Eyes with neovascular age-related macular degeneration that switched to faricimab generally had lower rates of lesion activity, longer treatment intervals and stable visual acuity.

Large language models may be helpful in generating scientific abstracts, according to research presented at the American Society of Retina Specialists annual meeting.